Role of SOX10 Immunohistochemical Expression in Diagnosing Triple Negative Breast Cancer and Its Correlation With Clinicopathological Features

被引:1
作者
Tariq, Muhammad Usman [1 ]
Siddiqui, Muhammad Afnan [2 ]
Din, Nasir Ud [3 ]
Kayani, Naila [3 ]
机构
[1] Al Hada Armed Forces Hosp, Histopathol, Taif, Saudi Arabia
[2] Indus Hosp & Hlth Network, Histopathol, Karachi, Pakistan
[3] Aga Khan Univ Hosp, Pathol & Lab Med, Karachi, Pakistan
关键词
tumor infiltrating lymphocytes; immunohistochemistry; tnbc; triple negative breast cancer; sox10; MELANOCYTIC NEOPLASMS; CARCINOMA; FREQUENCY; UTILITY;
D O I
10.7759/cureus.59276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Triple -negative breast cancer (TNBC) poses a diagnostic challenge for histopathologists due to the reduced frequency of breast -specific markers. SOX10 has emerged as a useful diagnostic marker for TNBC. The aim of our study was to determine the frequency of SOX -10 immunohistochemical (IHC) expression in our cohort and assess its correlation with clinicopathological and histological features. Materials and methods: We included 72 primary TNBC cases. Specimens included tru-cut biopsies and excision specimens. We stained whole slide sections of these specimens with SOX10 antibody and calculated its frequency (%) of expression and H -score. We applied the chi-square test to assess the correlation between SOX10 expression and clinicopathological and histological features such as the patient's age, specimen type, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, tumor -infiltrating lymphocytes (TILs), necrosis, calcification, lymphovascular invasion (LVI), lymph node involvement, T stage, and N stage. Results: SOX10 expression was observed in 42 (58.3%) cases with a median H -score of 57.5. The expression was significantly higher in tru-cut biopsy specimens as compared to excision specimens (73.5 vs 41.7%) and TILs negative tumors as compared to TILs positive tumors (64.3% vs 27.3). Metaplastic carcinoma showed reduced expression when compared with non-metaplastic tumors (35.7% vs 63.8%), but statistical significance was not achieved. No correlation was observed with the patient's age, tumor size, histological type, histological grade, nuclear pleomorphism, mitotic count, necrosis, calcification, LVI, lymph node involvement, T stage, and N stage. Conclusion: SOX10 was expressed in more than half of the TNBC cases of our study which not only highlights its diagnostic utility but advocated its application in combination with other breast -specific markers. The expression didn't correlate with the majority of clinicopathological and histological features, but correlation with tru-cut biopsy specimens and absence of TILs draws attention towards possible roles of proper fixation and host immunity, respectively.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
    Abuderman, Abdulwahab A.
    Harb, Ola A.
    Gertallah, Loay M.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2020, 24 (02): : 87 - 95
  • [32] Cytokeratin 7, GATA3, and SOX-10 is a Comprehensive Panel in Diagnosing Triple Negative Breast Cancer Brain Metastases
    Statz, Eric
    Jorns, Julie M.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2021, 29 (05) : 470 - 474
  • [33] Clinicopathological and prognostic characteristic features of triple negative and nontriple negative breast cancer at a tertiary care hospital
    Mohapatra, Manisha
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1186 - 1193
  • [34] Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers
    Choi, Junjeong
    Jung, Woo-Hee
    Koo, Ja Seung
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (11) : 1481 - 1493
  • [35] Clinicopathological and Prognostic Significance of Programmed Death Ligand-1 SP142 Expression in 132 Patients With Triple-negative Breast Cancer
    Chu, Jinah
    Yeo, Min-Kyung
    Lee, Sang Hwa
    Lee, Mi Yeon
    Chae, Seoung Wan
    Kim, Hyun-Soo
    Do, Sung-Im
    IN VIVO, 2022, 36 (06): : 2890 - 2898
  • [36] Expression of 14-3-3γ in patients with breast cancer: Correlation with clinicopathological features and prognosis
    Song, Yulan
    Yang, Zheng
    Ke, Zunfu
    Yao, Yunhong
    Hu, Xinrong
    Sun, Yanqin
    Li, Hongmei
    Yin, Jinbao
    Zeng, Chao
    CANCER EPIDEMIOLOGY, 2012, 36 (06) : 533 - 536
  • [37] Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer
    Abdelrahman, Aziza E.
    Rashed, Hayam E.
    Abdelgawad, Mohamed
    Abdelhamid, Mohamed I.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 28 : 43 - 53
  • [38] Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study
    Elwan, Amira
    Abdelrahman, Aziza E.
    Alnagar, Ahmed A.
    Abdelhamid, Mohamed, I
    Nawar, Nashwa
    TURKISH JOURNAL OF PATHOLOGY, 2021, 37 (02) : 121 - 129
  • [39] Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile
    Prutianu, Iulian
    Giusca, Simona Eliza
    Gafton, Bogdan
    Chifu, Mariana Bianca
    Terinte, Cristina
    Antonescu, Alexandra
    Popovici, Larisa
    Caruntu, Irina-Draga
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2024, 65 (02) : 209 - 216
  • [40] Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
    Sjekloca, Nikoleta
    Tomic, Snjezana
    Mrklic, Ivana
    Vukmirovic, Filip
    Vuckovic, Ljiljana
    Lovasic, Ingrid Belas
    Maras-Simunic, Marina
    MEDICINE, 2020, 99 (07)